NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
29/11/2022
Voltar para busca
Dado oficial do USPTO
PDMO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
29/11/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 40, 42
Data de depósito
23/12/2020
Data de registro
29/11/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/11/2022
Última transação
29/11/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Northumberland, GB
Examinador
BARRETT, LEAH N
Unidade examinadora
L60
Localização atual
TMEG LAW OFFICE 106
Titulares e representantes
Titulares
Sterling Pharma Solutions Limited
Representantes
Sarah Anne Keefe WOMBLE BOND DICKINSON (US) LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diabetesearnose and throat disordersepilepsygenetic disordershematological disordershormonal disordersinfectious diseaseslymphomametabolic disordersmouth and dental disordersmusculoskeletal disordernon-malignant disordernutritional disorderspainrare ophthalmological diseasesrare cancersrare infectious diseasesrare genetic diseasesrare respiratory diseasesrare central nervous system diseasesrare gastrointestinal diseasesrare immunological diseasesrare cardiovascular diseasesrare dermatological diseasesrare urinary system and sex hormone diseasesrare womens health diseasesrare earnosethroat diseasesanimal health disorderscardiovascular diseases and disorderscentral nervous system disordersdermatologic disordersendocrine system disordersgastrointestinal diseasesgenito urinary system and sex hormone imbalancesmale health disorderswomen's health disordersmental health disordersmusculoskeletal disordersrenal disorderscancerophthalmic disordersrenal diseasesrespiratory diseasestrauma and injury
Classe 5
Pharmaceuticalspsychotropicsantihelminticsanti-infectiveslipid lowering agentsinducers of erectionsinduction agentsneuromuscular blocking agentssedativesanti-cancer medicationanti-inflammatoriesanti-fungalsanti-bacterialsanti-spasmodicsappetite stimulantsbronchodilatorsappetite suppressantsanti-convulsivesneuroprotective drugsanti-anxiety medicationanti-depressantsanti-ischemicsanti-psychotics; pharmaceutical preparations for treating diabetesearnose and throat disordersepilepsygenetic disordershematological disordershormonal disordersinfectious diseaseslymphomametabolic disordersmouth and dental disordersmusculoskeletal disordernon-malignant disordernutritional disorderspainrare ophthalmological diseasesrare cancersrare infectious diseasesrare genetic diseasesrare respiratory diseasesrare central nervous system diseasesrare gastrointestinal diseasesrare immunological diseasesrare cardiovascular diseasesrare dermatological diseasesrare urinary system and sex hormone diseasesrare womens health diseasesrare earnosethroat diseases; Pharmaceuticalspharmaceutical preparations and substances for the treatment of viralinfectiousmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders for medical or veterinary purposes; vaccines; medicine for treating diabetesearnose and throat disordersepilepsygenetic disordershematological disordershormonal disordersinfectious diseaseslymphomametabolic disordersmouth and dental disordersmusculoskeletal disordernon-malignant disordernutritional disorderspainrare ophthalmological diseasesrare cancersrare infectious diseasesrare genetic diseasesrare respiratory diseasesrare central nervous system diseasesrare gastrointestinal diseasesrare immunological diseasesrare cardiovascular diseasesrare dermatological diseasesrare urinary system and sex hormone diseasesrare womens health diseasesrare earnosethroat diseases; chemical preparations for use in the pharmaceutical industrynamely for treating diabetesearnose and throat disordersepilepsygenetic disordershematological disordershormonal disordersinfectious diseaseslymphomametabolic disordersmouth and dental disordersmusculoskeletal disordernon-malignant disordernutritional disorderspainrare ophthalmological diseasesrare cancersrare infectious diseasesrare genetic diseasesrare respiratory diseasesrare central nervous system diseasesrare gastrointestinal diseasesrare immunological diseasesrare cardiovascular diseasesrare dermatological diseasesrare urinary system and sex hormone diseasesrare womens health diseasesrare earnosethroat diseasesanimal health disorderscardiovascular diseases and disorderscentral nervous system disordersdermatologic disordersendocrine system disordersgastrointestinal diseasesgenito urinary system and sex hormone imbalancesmale health disorderswomen's health disordersmental health disordersmusculoskeletal disordersrenal disorderscancerophthalmic disordersrenal diseasesrespiratory diseasestrauma and injury
Classe 40
Custom manufacture of pharmaceuticals; processing of pharmaceuticalsnamely treatment in the nature of chemical processing of chemicalbiochemical and pharmaceutical products for third parties; custom manufacturing services in the nature of processing of pharmaceutical preparations; processing of pharmaceutical preparationsassembly of products for othersprocessing of pharmaceuticalsmedicinesbiological preparations to the order and specification of others; treatment in the nature of chemical processing of chemicalbiochemical and pharmaceutical products for third parties; treatment of materialspharmaceuticalbiologicchemical products and their components used in the manufacture of pharmaceuticalsbiotherapeutic productsbiopharmaceuticals; treatment and destruction of pharmaceutical waste; informationadvice and consultancy services in relation to the aforesaid services
Classe 42
Pharmaceutical research services; pharmaceutical drug development services; pharmaceutical design servicesshaping and designing pills; testing of pharmaceuticals; conducting clinical trials for others relating to pharmaceuticals and chemicals; pharmaceutical analysischemical composition analysistestinganalysisevaluation of pharmaceuticals to determine conformity with certification standards; pharmaceutical laboratory research services relating to pharmaceuticals; pharmaceutical product evaluation; inspection of pharmaceuticals; biological research services; quality control and authentication services for others in the field of pharmaceuticals; informationadvice and consultancy services in relation to the aforesaid services
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
29/11/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/09/2022
PUBO
PUBLISHED FOR OPPOSITION
13/09/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/08/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/08/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
02/08/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/08/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
02/08/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/08/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
27/07/2022
PBER
WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST
27/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/07/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
19/07/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
19/07/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
19/07/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
19/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/06/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
30/06/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
24/01/2022
GNFR
FINAL REFUSAL E-MAILED
24/01/2022
CNFR
FINAL REFUSAL WRITTEN
24/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/12/2021
ALIE
ASSIGNED TO LIE
28/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/12/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
25/06/2021
GNRT
NON-FINAL ACTION E-MAILED
25/06/2021
CNRT
NON-FINAL ACTION WRITTEN
25/06/2021
DOCK
ASSIGNED TO EXAMINER
21/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/03/2021
NWAP
NEW APPLICATION ENTERED
26/12/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PDMO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.